Amedisys Price to Book Ratio 2010-2024 | AMED

Historical price to book ratio values for Amedisys (AMED) over the last 10 years. The current price to book ratio for Amedisys as of September 19, 2024 is 2.70.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Amedisys Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-09-20 97.30 2.70
2024-06-30 91.80 $36.01 2.55
2024-03-31 92.16 $34.97 2.64
2023-12-31 95.06 $34.28 2.77
2023-09-30 93.40 $33.51 2.79
2023-06-30 91.44 $32.53 2.81
2023-03-31 73.55 $34.83 2.11
2022-12-31 83.54 $34.04 2.45
2022-09-30 96.79 $32.93 2.94
2022-06-30 105.12 $32.04 3.28
2022-03-31 172.29 $31.34 5.50
2021-12-31 161.88 $30.03 5.39
2021-09-30 149.10 $29.11 5.12
2021-06-30 244.93 $26.89 9.11
2021-03-31 264.79 $24.24 10.92
2020-12-31 293.33 $24.71 11.87
2020-09-30 236.43 $23.10 10.24
2020-06-30 198.54 $22.26 8.92
2020-03-31 183.54 $21.01 8.74
2019-12-31 166.92 $19.87 8.40
2019-09-30 131.01 $18.71 7.00
2019-06-30 121.41 $17.52 6.93
2019-03-31 123.26 $16.27 7.58
2018-12-31 117.11 $15.09 7.76
2018-09-30 124.96 $13.98 8.94
2018-06-30 85.46 $12.86 6.64
2018-03-31 60.34 $16.14 3.74
2017-12-31 52.71 $15.20 3.47
2017-09-30 55.96 $15.13 3.70
2017-06-30 62.81 $14.57 4.31
2017-03-31 51.09 $14.33 3.56
2016-12-31 42.63 $13.73 3.11
2016-09-30 47.44 $13.30 3.57
2016-06-30 50.48 $12.77 3.95
2016-03-31 48.34 $12.32 3.92
2015-12-31 39.32 $12.21 3.22
2015-09-30 37.97 $11.70 3.25
2015-06-30 39.73 $11.29 3.52
2014-12-31 29.35 $11.84 2.48
2014-09-30 20.17 $11.49 1.76
2014-06-30 16.74 $11.18 1.50
2014-03-31 14.89 $11.13 1.34
2013-12-31 14.63 $11.45 1.28
2015-03-31 26.78 $10.92 2.45
2013-09-30 17.21 $11.66 1.48
2013-06-30 11.60 $14.48 0.80
2013-03-31 11.12 $14.71 0.76
2012-12-31 11.31 $14.61 0.77
2012-09-30 13.82 $18.08 0.76
2012-06-30 12.45 $17.28 0.72
2012-03-31 14.46 $17.25 0.84
2011-12-31 10.91 $17.55 0.62
2011-09-30 14.82 $17.05 0.87
2011-06-30 26.63 $31.11 0.86
2011-03-31 35.00 $30.71 1.14
2010-12-31 33.50 $30.09 1.11
2010-09-30 23.80 $29.95 0.79
2010-06-30 43.98 $28.78 1.53
2010-03-31 55.22 $27.59 2.00
2009-12-31 48.60 $26.12 1.86
2009-09-30 43.63 $24.57 1.78
2009-06-30 33.02 $23.19 1.42
2009-03-31 27.49 $21.91 1.25
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.183B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.223B 12.84
Quest Diagnostics (DGX) United States $17.268B 17.71
DaVita (DVA) United States $13.687B 16.84
Encompass Health (EHC) United States $9.264B 22.79
Chemed (CHE) United States $8.808B 27.08
Elanco Animal Health (ELAN) United States $7.449B 16.74
Option Care Health (OPCH) United States $5.396B 26.51
RadNet (RDNT) United States $5.150B 122.18
Astrana Health (ASTH) United States $2.839B 40.17
LifeStance Health (LFST) United States $2.625B 0.00
Addus HomeCare (ADUS) United States $2.408B 29.24
U.S Physical Therapy (USPH) United States $1.282B 34.70
Pennant (PNTG) United States $1.076B 51.61
Aveanna Healthcare Holdings (AVAH) United States $1.063B 0.00
Atai Life Sciences (ATAI) Germany $0.211B 0.00
Daxor (DXR) United States $0.044B 0.00
ATI Physical Therapy (ATIP) United States $0.025B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.010B 0.00
Novo Integrated Sciences (NVOS) United States $0.006B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00